Symbolbild · KI-generiert
PharmaCorp Rx Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
PharmaCorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. Through a combination of capital, strategic support and operational expertise, PharmaCorp is building a national network of community pharmacies under the PharmaChoice Canada banner. PharmaCorp currently operates 15 PharmaChoice Canada-bannered pharmacies and intends to continue acquiring both PharmaChoice Canada-bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform in accordance with its strategic alliance with PharmaChoice Canada, where applicable. PharmaCorp shares trade on the TSX Venture Exchange under the symbol PCRX. PharmaCorp welcomes discussions with pharmacy owners considering succession or sale. For more information about PharmaCorp's acquisition program and process, please visit www.PharmaCorpRx.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| PharmaCorp Rx Inc. | PCRX | TSXV | 70 Mio. USD |
| Charlotte's Web Holdings Inc. | CWEB | TSX | 62 Mio. USD |
| Leef Brands Inc. | LEEF | CSE | 61 Mio. USD |
| Jushi Holdings Inc. Class B Subordinate Voting Shares | JUSH | CSE | 83 Mio. USD |
| Enablence Technologies Inc. | ENA | TSXV | 83 Mio. USD |
| Immutep | IMMP | NASDAQ | 56 Mio. USD |
| Rallybio | RLYB | NASDAQ | 84 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.